To analyze tissue-specific requirements of SMN, we used RNA interference (RNAi) to create a series of loss of function Smn alleles, whose phenotypes mimic the dosage dependent nature of SMA pathology. Here, SMN2 is linked to proximal spinal muscular atrophy.